icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
Virtual
February 12-16, 2022
Back grey_arrow_rt.gif
 
 
 
EFFICACY & SAFETY OF RAVIDASVIR + SOFOSBUVIR
IN HEPATITIS C: STORM-C-1 FINAL RESULTS
 
 
  CROI 2022 Feb 11-16
 
Soek-Siam Tan1, Sombat Thanprasertsuk2, Satawat Thongsawat3, Nicolas Salvadori4, Caroline Menétrey5, STORM-C-1 Research Team*
1Selayang Hospital, Department of Hepatology, Malaysia; 2Department of Disease Control, Ministry of Public Health, Bangkok, Thailand; 3Chiang Mai University, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand; 4Chiang Mai University, Faculty of Associated Medical Sciences, PHPT/IRD, Chiang Mai, Thailand; 5Drugs for Neglected Diseases initiative, Geneva, Switzerland

0324221

0324222

0324223

0324224

0324225